In addition to PD-L1 expression levels in cancer cells, several candidate predictive biomarkers were investigated including gene alterations and phenotypic alternations [13, 14], tumor microenvironments and immune effector cells [15, 16], and clinicopathologic factors [17, 18]. Here, CD274 is linked to neoplasm.